Building Capacity for Tobacco Dependence Treatment in Japan: New Request for Proposals
Global Bridges: Healthcare Alliance for Tobacco Dependence Treatment, hosted at Mayo Clinic, and Pfizer Inc., in collaboration with the Japan Cancer Society, are pleased to announce a new grant opportunity focused on building capacity to treat tobacco dependence in Japan.
Since 2010, Global Bridges and Pfizer Inc. have collaborated to support 30 grant projects, managed independently by grantee organizations around the world. Many of these projects have developed and implemented culturally-appropriate curricula to train healthcare professionals on evidence-based treatment techniques. Others have conducted national situation analyses to inform and strengthen government treatment policy. More on previous grant projects can be found here. The Japan Cancer Society has spearheaded nationwide cancer prevention efforts for more than 50 years and its mission includes working toward a tobacco-free society.
The new opportunity leverages the experience of all three organizations to address the unique needs of tobacco control and tobacco dependence treatment among healthcare professionals in Japan. Mayo Clinic, Japan Cancer Society, and Pfizer Inc. are pleased to offer this opportunity for qualified organizations to aid in reducing the death and disease caused by tobacco use in Japan. Please note that applications will be accepted in Japanese language.